Updates in the management of cranial dural arteriovenous fistula

Dural arteriovenous fistula (dAVF) accounts for approximately 10% of all intracranial vascular malformations. While they can be benign lesions, the presence of retrograde venous drainage and cortical venous reflux makes the natural course of these lesions aggressive high risk of haemorrhage, neurolo...

Full description

Saved in:
Bibliographic Details
Published inStroke and vascular neurology Vol. 5; no. 1; pp. 50 - 58
Main Authors Baharvahdat, Humain, Ooi, Yinn Cher, Kim, Wi Jin, Mowla, Ashkan, Coon, Alexander L, Colby, Geoffrey P
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.03.2020
BMJ Publishing Group LTD
BMJ Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dural arteriovenous fistula (dAVF) accounts for approximately 10% of all intracranial vascular malformations. While they can be benign lesions, the presence of retrograde venous drainage and cortical venous reflux makes the natural course of these lesions aggressive high risk of haemorrhage, neurological injury and mortality. Endovascular treatment is often the first line of treatment for dAVF. Both transarterial and transvenous approaches are used to cure dAVF. The selection of treatment approach depends on the angioarchitecture of the dAVF, the location, the direction of venous flow. Surgery and, to a lesser extent, stereotactic radiosurgery are used when endovascular approaches are impossible or unsuccessful.
ISSN:2059-8688
2059-8696
DOI:10.1136/svn-2019-000269